Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 May 2:4:18.
doi: 10.1186/1758-3284-4-18.

Expression of Glut-1, HIF-1α, PI3K and p-Akt in a case of ceruminous adenoma

Affiliations
Case Reports

Expression of Glut-1, HIF-1α, PI3K and p-Akt in a case of ceruminous adenoma

Wan-Qin Shen et al. Head Neck Oncol. .

Expression of concern in

  • Comment: Head and Neck Oncology.
    BioMed Central. BioMed Central. BMC Med. 2014 Feb 5;12:24. doi: 10.1186/1741-7015-12-24. BMC Med. 2014. PMID: 24499430 Free PMC article. Review.

Abstract

Objectives: Ceruminous adenoma of the external auditory canal (EAC) is a rare type of tumour that is diagnosed histologically. However, the clinical behaviour of these tumours remains controversial. Here, we report a case of ceruminous adenoma of the EAC and expression of a hypoxia marker.

Case report: A 78-year-old man presented with a 6-month history of recurrent otorrhoea in the right ear. Surgery was performed by the transmeatal approach with total removal of the mass. Histopathology revealed a ceruminous adenoma. Tumour cells were positive for CK, S-100 protein, Glut-1, HIF-1α, PI3K and p-Akt. There was no evidence of recurrence at last follow-up 27 months after the operation.

Conclusions: Ceruminous adenoma of the EAC is a rare tumour. The treatment of choice is wide local excision with clear margins. To our knowledge, this is the first report of Glut-1 expression and the PI3K/Akt pathway in ceruminous adenoma of the EAC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CT showed a 0.5×0.5cm soft lesion in the right EAC with no signs of bone destruction.
Figure 2
Figure 2
Immunohistochemistry analyses for the expression of Glut-1, HIF-1α, PI3K and p-Akt. The tumor cells were positive for Glut-1(A) (EliVision×20), HIF-1α(B) (EliVision×10), PI3K(C) (EliVision×40) and p-Akt(D) (EliVision×10).

References

    1. Mills RG, Douglas-Jones T, Williams RG. Ceruminoma–-a defunct diagnosis. J Laryngol Otol. 1995;109:180–188. - PubMed
    1. Giuseppe M, Serena B, Sandro B, Cristiano DN, Vincenzo S, Tommaso V, Francesco Z. Adenoma of the ceruminous gland (ceruminoma) Otol Neurotol. 2011;32:e14–e15. doi: 10.1097/MAO.0b013e3181db7545. - DOI - PubMed
    1. Mansour P, George MK, Pahor AL. Ceruminous gland tumours: a reappraisal. J Laryngol Otol. 1992;106:727–732. doi: 10.1017/S0022215100120717. - DOI - PubMed
    1. Friedmann I. Pathological lesions of the external auditory meatus: a review. J R Soc Med. 1990;83:34–37. - PMC - PubMed
    1. Thompson LD, Nelson BL, Barnes EL. Ceruminous adenomas: a clinicopathologic study of 41 cases with a review of the literature. Am J Surg Pathol. 2004;28:308–318. doi: 10.1097/00000478-200403000-00003. - DOI - PubMed

Publication types

MeSH terms

Substances